Healthcare & Life Sciences
Crystalys Therapeutics
Denmark
series-b
series-b
Stage
4
Investors
About
Crystalys Therapeutics is a biotechnology company developing selective therapies for cancer and immune diseases by targeting lysosomal pathways.
Explore Crystalys Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.